Esketamine | Jotup

Mount Sinai Health System Named to Modern Healthcare’s 2024 Innovators list

Retrieved on:

onsdag, april 10, 2024

FDA, Organization, Risk, Food, Invention, Research, Culture, Mount Sinai Health System, DSM-IV codes, Esketamine, Modern Healthcare, Patient, Health, Wisconsin Public Radio, Food and Drug Administration, Pharmaceutical industry

Mount Sinai Health System, April 10, 2024 (GLOBE NEWSWIRE) -- New York, NY (April 9, 2024) – Mount Sinai Health System today announced that it has been named one of Modern Healthcare’s Innovators for 2024, an award that recognizes leaders and organizations driving innovation that improves care, achieves measurable results, and contributes to the clinical and financial goals of the organization.

Key Points:

Mount Sinai Health System, April 10, 2024 (GLOBE NEWSWIRE) -- New York, NY (April 9, 2024) – Mount Sinai Health System today announced that it has been named one of Modern Healthcare’s Innovators for 2024, an award that recognizes leaders and organizations driving innovation that improves care, achieves measurable results, and contributes to the clinical and financial goals of the organization.
These include the Mount Sinai Ideas Network , an innovation platform that encourages new collaborations and partnerships to advance Mount Sinai discoveries.
“At Mount Sinai, we cultivate an innovative environment that helps propel the health care industry forward,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System.
Profiles of Modern Healthcare’s 2024 Innovators honorees are featured in the April 8, 2024, issue of MH magazine and online at ModernHealthcare.com/Innovator-Awards .

Johnson & Johnson Reports Q1 2024 Results

Retrieved on:

tisdag, april 16, 2024

Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Medtech, Patient, News, Pulmonary hypertension, Johnson & Johnson, Security (finance), Relapse, Press release, Esketamine, General surgery, Daratumumab, COVID-19, Pharmaceutical industry

First Quarter 2024 Segment Commentary:

Key Points:

First Quarter 2024 Segment Commentary:
Operational sales* reflected below excludes the impact of translational currency.
Adjusted operational sales* reflected below excludes the net impact of acquisitions and divestitures and translational currency.
Notable New Announcements in the Quarter:
The information contained in this section should be read together with Johnson & Johnson’s other disclosures filed with the Securities and Exchange Commission, including its Current Reports on Form 8-K, Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K.
Copies of these filings are available online at www.sec.gov , www.jnj.com or on request from Johnson & Johnson.

Turnwell Mental Health Continues Expansion, Opens First Location in South Carolina

Retrieved on:

tisdag, april 23, 2024

Esketamine, FDA, Suite, OCD, Geriatrics, Transcranial magnetic stimulation, Insurance, MD, Depression, Neuronavigation, South Carolina Lowcountry, Mental health, Patient, Medicare, Anxiety, Mental, TMS, Nursing

CHARLESTON, S.C., April 23, 2024 /PRNewswire/ -- Turnwell Mental Health is proud to announce the grand opening of its newest location in Mount Pleasant, South Carolina. With two board certified Psychiatrists, Turnwell Mental Health offers quality mental health services to adults and adolescents ages 10+ in the tri-county area for the treatment of depression, anxiety, OCD, and many other diagnoses.

Key Points:

CHARLESTON, S.C., April 23, 2024 /PRNewswire/ -- Turnwell Mental Health is proud to announce the grand opening of its newest location in Mount Pleasant, South Carolina.
With two board certified Psychiatrists, Turnwell Mental Health offers quality mental health services to adults and adolescents ages 10+ in the tri-county area for the treatment of depression, anxiety, OCD, and many other diagnoses.
"We are thrilled to bring Turnwell Mental Health to the vibrant community of Charleston," said Dr. Ashley Collins, DO of Turnwell Mental Health South Carolina.
"We are excited to introduce our services to the Charleston community and the broader Lowcountry area," said Dr. Brandon Lilly, MD of Turnwell Mental Health South Carolina.

Psychiatry Office Opens New Location in Wall Township

Retrieved on:

tisdag, april 16, 2024

Esketamine, Patient, System, ADD, Counselor, Depression, Open House, The Open House, 3rd millennium, Freehold, Anxiety, Senior counsel, Mental health, Practitioner, Social, TMS

WALL TOWNSHIP, N.J., April 16, 2024 /PRNewswire/ -- With two locations already open in Westfield, Embrace Psychiatric Wellness Center has opened a new location in Wall Township, New Jersey, in March 2024. To better serve patients in the area, the Freehold and Brick offices were combined into one larger, newly renovated location, located at 2111 NJ-34.

Key Points:

Embrace Psychiatric Wellness Center Aims to Serve More Patients in Wall Township, NJ
WALL TOWNSHIP, N.J., April 16, 2024 /PRNewswire/ -- With two locations already open in Westfield, Embrace Psychiatric Wellness Center has opened a new location in Wall Township, New Jersey, in March 2024.
To better serve patients in the area, the Freehold and Brick offices were combined into one larger, newly renovated location, located at 2111 NJ-34.
As an insurance-friendly practice, Embrace Psychiatric Wellness Center is in-network with major plans, making treatment more affordable and easier for more individuals and families in the Wall Township area.
The Wall Township office is now accepting new patients, so if you have mental health concerns, contact Embrace Psychiatric Wellness Center today!

Spravato® Therapy at Hudson Mind Ushers in New Era of Accessible Care for Treatment-Resistant Depression

Retrieved on:

tisdag, april 16, 2024

Esketamine, FDA, Brain, Post-traumatic stress disorder, Thought, Insurance, Transcranial magnetic stimulation, Depression, Tic disorder, Patient, Mental health, Ketamine, Anxiety, Nursing

NEW YORK, April 11, 2024 /PRNewswire/ -- Hudson Mind, an interventional mental health clinic in New York City, announces the addition of Spravato® (https://mind.hudson.health/treatments/spravato/). The integration of Spravato opens the door to more accessible treatment options for patients with major depression.

Key Points:

NEW YORK, April 11, 2024 /PRNewswire/ -- Hudson Mind, an interventional mental health clinic in New York City, announces the addition of Spravato® ( https://mind.hudson.health/treatments/spravato/ ).
The integration of Spravato opens the door to more accessible treatment options for patients with major depression.
Hudson Mind psychiatrist Dr. Marcel Green is eager to introduce more patients to the burgeoning interventional mental health landscape, starting with Spravato.
"At Hudson Mind, we emphasize that ketamine represents a revolutionary advancement in mental health care.

Cathy Nguyen Named Provider of the Month at Relief Mental Health in Chicago

Retrieved on:

tisdag, april 2, 2024

Relief Mental Health , a leading outpatient provider of transcranial magnetic stimulation (TMS), psychedelic therapy, psychiatric medication management, and talk therapy, is thrilled to announce Psychiatric Nurse Practitioner Cathy Nguyen, MSN APRN PMHNP-BC as its esteemed Provider of the Month.

Key Points:

Relief Mental Health , a leading outpatient provider of transcranial magnetic stimulation (TMS), psychedelic therapy, psychiatric medication management, and talk therapy, is thrilled to announce Psychiatric Nurse Practitioner Cathy Nguyen, MSN APRN PMHNP-BC as its esteemed Provider of the Month.
Nguyen has exhibited exceptional dedication and expertise in providing innovative mental health care to the community at Relief’s West Loop clinic in Chicago.
Susan Mueller, CEO of Relief Mental Health, expressed her admiration for Nguyen’s commitment to the organization’s core values.
To make an appointment with Nguyen or for more information about the innovative services offered at Relief Mental Health, call 855.205.4764, email [email protected] or visit reliefmh.com .

Psychedelics set to be the revolutionary treatments in pscyhiatry- Thelansis Knowledge Partners

Retrieved on:

torsdag, februari 22, 2024

Availability of psychedelic(s) with few administrations in a year and offering high remission rate could change the treatment pathway for these patients."

Key Points:

Availability of psychedelic(s) with few administrations in a year and offering high remission rate could change the treatment pathway for these patients."
According to an interviewed U.S.-based neurologist by Thelansis – "We desperately need disease-modifying treatments for many neurodegenerative conditions.
As psychedelics would be beneficial for treatment-nonresponders or severe patients, the commercial opportunities are multiple for in-pipeline psychedelic therapies.
What is the probable opportunity for Psychedelics (e.g., psilocybin, MDMA) to address the unmet needs of other TAs?

Psychedelics set to be the revolutionary treatments in pscyhiatry - Thelansis Knowledge Partners

Retrieved on:

torsdag, februari 22, 2024

Availability of psychedelic(s) with few administrations in a year and offering high remission rate could change the treatment pathway for these patients."

Key Points:

Availability of psychedelic(s) with few administrations in a year and offering high remission rate could change the treatment pathway for these patients."
According to an interviewed U.S.-based neurologist by Thelansis – "We desperately need disease-modifying treatments for many neurodegenerative conditions.
As psychedelics would be beneficial for treatment-nonresponders or severe patients, the commercial opportunities are multiple for in-pipeline psychedelic therapies.
What is the probable opportunity for Psychedelics (e.g., psilocybin, MDMA) to address the unmet needs of other TAs?

Avesta Partners with Veterans Affairs (VA) to Offer Free Ketamine Therapy to Eligible Veterans

Retrieved on:

onsdag, februari 21, 2024

Anxiety, Esketamine, TRD, Ketamine, Suicide, History, Chronic pain, Depression, Patient, Teaching, PTSD, Veteran, Senior counsel, Veterans' affairs, Partnership

WASHINGTON, Feb. 21, 2024 /PRNewswire/ -- Avesta Ketamine and Wellness ("Avesta"), a leading provider of innovative mental health treatments, announced a partnership with Veterans Affairs (VA) to offer free ketamine therapy to eligible veterans. This initiative, available now in Avesta ketamine clinics across Washington, DC, Northern Virginia, and Bethesda, Maryland, will help veterans overcome treatment-resistant depression (TRD), PTSD, anxiety, chronic pain, and substance misuse disorders.

Key Points:

WASHINGTON, Feb. 21, 2024 /PRNewswire/ -- Avesta Ketamine and Wellness ("Avesta"), a leading provider of innovative mental health treatments, announced a partnership with Veterans Affairs (VA) to offer free ketamine therapy to eligible veterans.
Avesta seeks to address these challenges by offering IV ketamine infusions and/or Spravato treatments to veterans who have not found relief through traditional therapies.
Avesta already partners with the Veterans Mental Health Coalition, a coalition committed to ending veterans' suicide, and views this new partnership as continuing its mission.
Thanks to Avesta's Veterans Care Agreement, veterans near McLean, Virginia, Bethesda, Maryland, and Washington D.C. are eligible to receive treatments at Avesta without financial burden.

Johnson & Johnson Reports Q4 and Full-Year 2023 Results

Retrieved on:

tisdag, januari 23, 2024

Adjusted operational sales* reflected below excludes the net impact of acquisitions and divestitures and translational currency.

Key Points:

Adjusted operational sales* reflected below excludes the net impact of acquisitions and divestitures and translational currency.
Innovative Medicine worldwide operational sales, excluding the COVID-19 Vaccine, grew 7.2%*.
Notable New Announcements in the Quarter:
The information contained in this section should be read together with Johnson & Johnson’s other disclosures filed with the Securities and Exchange Commission, including its Current Reports on Form 8-K, Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K.
Copies of these filings are available online at www.sec.gov , www.jnj.com or on request from Johnson & Johnson.